Valley is aware of the nationwide supply disruption of IV fluid solution due to Hurricane Helene, and wants to reassure the community that steps have been taken to ensure the situation will have no negative impact on our patients and the community.
To view the clinical trials Valley currently has available, please use the search field or select a clinical specialty from the drop-down list below. Be sure to check back frequently, as we are always adding new studies.
For more information about any of our clinical trials, please email [email protected] or call 201-447-8453. (For cancer clinical trials, please call 201-634-5792.)
A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)
Principal Investigator(s): Rupa G. Juthani, MD
Status: Open and enrolling
QOD Quality Improvement Registry
Principal Investigator(s): Rupa G. Juthani, MD
Status: Open and enrolling
A Randomized Phase III Trial of Pre-Operative Compared to Post-Operative Stereotactic Radiosurgery in Patients With Resectable Brain Metastases
Principal Investigator(s): Rupa G. Juthani, MD
Status: Open and enrolling
AANS NPA Stereotactic Radiosurgery (SRS) Registry
Principal Investigator(s): William S. Cobb, MD, PhD
Status: Open and enrolling
A Three-part, Phase I/II Dose-Escalation Study to Define the Safety, Tolerability, and Optimal Dose of Candidate GBM vaccine VBI-1901 with Subsequent Extension of Optimal Dose in Recurrent GBM subjects.
Principal Investigator(s): William S. Cobb, MD, PhD
Status: Open and enrolling